|
GNTA. cancer drug. waiting on fda approval. recently hired new sales/distribution executives. up 10.45% today as of this post. great volume. new 52 week high. with no news today. could be a $20 stock by Dec if it's approved. yeah, it's a risky biotech stock and the daytraders love to play with it. no risk, no reward.
|